Novo Nordisk drops 10% as heart drug fails in Phase III
Novo Nordisk shares fell 10% last week after its experimental cardiovascular drug ziltivekimab failed to prevent heart attacks, strokes or cardiovascu
Every Fin-node story mentioning AstraZeneca — 3 stories, newest first.
Novo Nordisk shares fell 10% last week after its experimental cardiovascular drug ziltivekimab failed to prevent heart attacks, strokes or cardiovascu
The Dow Jones Industrial Average closed at a record high Monday as optimism around U.S.-Iran talks lifted sentiment, though the session's sector rotat
AstraZeneca shares dropped 6.1 per cent to 11,860p in early London trading on Monday after the Financial Times reported the UK drugmaker has held talk